Cabaletta Bio (CABA) Amortizatization of Intangibles (2020 - 2025)
Cabaletta Bio (CABA) recorded quarterly Amortizatization of Intangibles of $890000.0 in Q4 2025, up 150.0% quarter-over-quarter from $356000.0 in Q3 2025, and up 808.16% on a YoY basis from $98000.0 in Q4 2024.
Cabaletta Bio (CABA) Amortizatization of Intangibles (2020 - 2025) Analysis & Trends
Cabaletta Bio's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $890000.0 for Q4 2025.
- In Q4 2025, Amortizatization of Intangibles rose 808.16% year-over-year to $890000.0; the TTM figure through Dec 2025 stood at $1.6 million (up 1.77% YoY), while the FY2025 annual figure was $1.6 million, up 1.77% from the prior year.
- Amortizatization of Intangibles was $890000.0 for Q4 2025 at Cabaletta Bio, up from $356000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.0 million in Q3 2024 to a low of -$224000.0 in Q2 2024.
- Historically, Amortizatization of Intangibles has averaged $249500.0 across 5 years, with a median of $101000.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Amortizatization of Intangibles soared 1575.0% in 2022, then plunged 338.3% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at $62000.0 in 2021, then soared by 719.35% to $508000.0 in 2022, then soared by 83.86% to $934000.0 in 2023, then sank by 89.51% to $98000.0 in 2024, then jumped by 808.16% to $890000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $890000.0 (Q4 2025), $356000.0 (Q3 2025), and $142000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Cabaletta Bio | 158.47 Mn | 24.88 Mn | - | 890,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 890,000.00 |
| Dec 31, 2025 | 890,000.00 |
| Sep 30, 2025 | 356,000.00 |
| Sep 30, 2025 | 356,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Mar 31, 2025 | 167,000.00 |
| Mar 31, 2025 | 167,000.00 |
| Dec 31, 2024 | 98,000.00 |
| Dec 31, 2024 | 98,000.00 |
| Sep 30, 2024 | 1.04 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | -224,000.00 |
| Jun 30, 2024 | -224,000.00 |
| Mar 31, 2024 | 617,000.00 |
| Mar 31, 2024 | 617,000.00 |
| Dec 31, 2023 | 934,000.00 |
| Dec 31, 2023 | 934,000.00 |
| Sep 30, 2023 | 90,000.00 |
| Sep 30, 2023 | 90,000.00 |